Norucholic acid for treating primary sclerosing cholangitis [ID6583]
Awaiting development
Reference number: GID-TA11782
Expected publication date: TBC
To appraise the clinical and cost effectiveness of Norursodeoxycholic acid within its marketing authorisation for treating primary
sclerosing cholangitis (PSC) ID6583